By: KJ Lavan The Convergence of Astrocyte Biology, Metabolism, and Neuropsychiatric Health A lready quietly unfolding at the frontiers of neuroscience and precision medicine is the era of “metabo-neuro” interventions , and astrocytes are a key to unlocking it. 🔬 Why Astrocytes? Astrocytes are no longer seen as just "support cells" in the brain. They are: Metabolic gatekeepers – regulating glucose and lactate delivery to neurons. Neurotransmitter modulators – recycling glutamate, shaping synaptic transmission. Neuroimmune mediators – producing cytokines, responding to systemic inflammation. Circadian regulators – influencing sleep, feeding, and energy homeostasis. In essence, astrocytes translate metabolic cues into neural outcomes. 🔁 The Metabo-Neuro Feedback Loop There’s a bi-directional dialogue between metabolic health and brain health: Systemic metabolic dysfunction (e.g., insulin resistance, obesity) → astrocyte inflammation →...
Popular posts from this blog
Resident T-Cells in Healthy Brains: A Paradigm Shift in Neuroimmunology
Here is a concise research brief summarizing the significance of the discovery of T cells in healthy brains and its implications for neuroinflammation and cognitive function research: Research Brief Title: Resident T Cells in Healthy Brains: A Paradigm Shift in Neuroimmunology Date: June 2025 Prepared for: Neuroscience and Immunology Research Stakeholders Author: KJ Lavan Background Historically, the brain has been viewed as an immune-privileged organ—largely insulated from systemic immune surveillance. T cells were thought to infiltrate the brain primarily during pathological events such as infections, trauma, or autoimmune diseases. However, new evidence (Source: The Subfornical Organ is a Nucleus for Gut-Derived T-Cells that Regulate Behavior, Yoshida, et al., Nature, 2025) reveals that T cells are not transient visitors but resident cells in healthy brains , raising critical questions about their function...
A World Economic Forum–Aligned Strategic Briefing on the Next Phase of Global Dementia Policy (2026–2030)
A World Economic Forum –Aligned Strategic Briefing on the Next Phase of Global Dementia Policy (2026–2030) Author: KJ Lavan https://www.linkedin.com/in/kj-lavan-1739ab226 From Advocacy to Infrastructure Prepared for: Global policymakers, multilateral institutions, ministries of health and finance, private capital, and civil society leaders Executive Summary Dementia is no longer solely a health-sector issue. It is a macroeconomic, demographic, and governance challenge that will materially shape global productivity, fiscal stability, and social cohesion over the next three decades. Globally: 55+ million people live with dementia today¹ Projected to reach 139 million by 2050 ¹ Annual global economic cost exceeds US$1.3 trillion , projected to surpass US$2.8 trillion by 2030 ² Informal caregivers contribute an estimated US$900+ billion in unpaid labor annually² Up to 40% of dementia cases are attributable to modifiable risk factors ³ The co...
Comments
Post a Comment